1. Home
  2. LRMR vs MEI Comparison

LRMR vs MEI Comparison

Compare LRMR & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • MEI
  • Stock Information
  • Founded
  • LRMR N/A
  • MEI 1946
  • Country
  • LRMR United States
  • MEI United States
  • Employees
  • LRMR N/A
  • MEI N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • MEI Electrical Products
  • Sector
  • LRMR Health Care
  • MEI Technology
  • Exchange
  • LRMR Nasdaq
  • MEI Nasdaq
  • Market Cap
  • LRMR 426.9M
  • MEI 402.1M
  • IPO Year
  • LRMR N/A
  • MEI N/A
  • Fundamental
  • Price
  • LRMR $3.34
  • MEI $11.87
  • Analyst Decision
  • LRMR Strong Buy
  • MEI Hold
  • Analyst Count
  • LRMR 8
  • MEI 3
  • Target Price
  • LRMR $19.63
  • MEI $14.00
  • AVG Volume (30 Days)
  • LRMR 678.8K
  • MEI 415.1K
  • Earning Date
  • LRMR 03-13-2025
  • MEI 03-06-2025
  • Dividend Yield
  • LRMR N/A
  • MEI 4.72%
  • EPS Growth
  • LRMR N/A
  • MEI N/A
  • EPS
  • LRMR N/A
  • MEI N/A
  • Revenue
  • LRMR N/A
  • MEI $1,087,900,000.00
  • Revenue This Year
  • LRMR N/A
  • MEI N/A
  • Revenue Next Year
  • LRMR N/A
  • MEI $5.77
  • P/E Ratio
  • LRMR N/A
  • MEI N/A
  • Revenue Growth
  • LRMR N/A
  • MEI N/A
  • 52 Week Low
  • LRMR $3.01
  • MEI $8.54
  • 52 Week High
  • LRMR $13.68
  • MEI $22.20
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 29.00
  • MEI 50.85
  • Support Level
  • LRMR $3.24
  • MEI $11.48
  • Resistance Level
  • LRMR $3.54
  • MEI $12.31
  • Average True Range (ATR)
  • LRMR 0.22
  • MEI 0.66
  • MACD
  • LRMR 0.03
  • MEI -0.03
  • Stochastic Oscillator
  • LRMR 12.26
  • MEI 62.39

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About MEI Methode Electronics Inc.

Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.

Share on Social Networks: